NKTXMICRO

Nkarta, Inc.

HealthcareBiotechnology
$3.15
$0.00(-5.12%)
52W$1.63
$3.65
Updated May 7, 12:00 AM
RSI67
RS Rating80/99
Beta2.07
Volatility69%
F-Score4/9
Mkt Cap$223M
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Nkarta, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 80), indicating clear outperformance against the broad market. Earnings growth of 26% provides fundamental context to the price action. However, price is extended 23% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
80
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
2.07
vs S&P 500
HIGH BETA
52W Position
75%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.56
50 SMA > 100 SMA$2.32
100 SMA > 150 SMA$2.23
150 SMA > 200 SMA$2.20

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.89+9.02%ABOVE
50 SMA$2.56+23.25%ABOVE
100 SMA$2.32+35.98%ABOVE
150 SMA$2.23+41.55%ABOVE
200 SMA$2.20+43.25%ABOVE

Price Performance

1D-5.1%
1W+13.7%
1M+40.0%
3M+56.7%
6M+60.7%
YTD+68.4%
1Y+68.4%
3Y-11.9%
52-Week Trading Range75% from low
$3.15
52W Low$1.63
52W High$3.65

Technical Indicators

RSI (14)BULLISH
66.9
305070
VCP ScoreCOOL
1/10
Base depth: 54.0%

Risk Profile

Beta
2.07
52W Vol
69%
ATR
$0.29
Max DD (1Y)
-34%

Volume Analysis

Today
1.03M
50D Avg
802.1K
Vol Ratio
1.28x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24+39%
$-0.35
Q1'25+26%
$-0.43
Q2'25+9%
$-0.31
Q3'25+26%
$-0.29
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+26.60%

Stock Price CAGR

10 Years:-23.83%
5 Years:-35.24%
3 Years:-11.86%
1 Year:+68.45%

Return on Equity

10Y Avg:-39.4%
5Y Avg:-39.4%
3Y Avg:-35.0%
Last Year:-30.4%

Key Metrics

Market Cap$223M
Gross Margin
Net Margin
Piotroski F-Score4/9

Frequently Asked Questions

Is NKTX in an uptrend right now?

NKTX has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, NKTX is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is NKTX overbought or oversold?

NKTX's RSI (14) is 67. The stock is in neutral territory, neither overbought nor oversold.

Is NKTX outperforming the market?

NKTX has a Relative Strength (RS) Rating of 80 out of 99. Yes, NKTX is a market leader, outperforming 80% of all stocks over the past 12 months.

Where is NKTX in its 52-week range?

NKTX is trading at $3.15, which is 86% of its 52-week high ($3.65) and 75% above its 52-week low ($1.63).

How volatile is NKTX?

NKTX has a Beta of 2.07 and 52-week volatility of 69%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.